Silencing of Pokemon Enhances Caspase-Dependent Apoptosis via Fas- and Mitochondria-Mediated Pathways in Hepatocellular Carcinoma Cells

PLoS ONE

Volumn 8, Issue 7, 2013, Pages

  Zhang, Yu Qin ^a   Xiao, Chuan Xing ^a   Lin, Bi Yun ^a   Shi, Ying ^a   Liu, Yun Peng ^a   Liu, Jing Jing ^a   Guleng, Bayasi ^a,b   Ren, Jian Lin ^a  

^a ZHONGSHAN HOSPITAL OF XIAMEN UNIVERSITY   (China)

^b XIAMEN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

APOPTOSIS INDUCING FACTOR; BIM PROTEIN; CASPASE; CASPASE 10; CASPASE 3; CASPASE 8; CASPASE 9; CYTOCHROME C; DEATH RECEPTOR; FAS ANTIGEN; FAS ASSOCIATED DEATH DOMAIN PROTEIN; OXALIPLATIN; POK ERYTHROID MYELOID ONTOGENIC ACTOR PROTEIN; PROTEIN BAD; PROTEIN BCL 2; PROTEIN BID; PROTEIN P53; PUMA PROTEIN; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CANCER CELL; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ACTIVITY; FLUORESCENCE ACTIVATED CELL SORTING; HUMAN; HUMAN CELL; LIVER CELL CARCINOMA; MITOCHONDRIAL MEMBRANE POTENTIAL; MITOCHONDRION; NICK END LABELING; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; WESTERN BLOTTING;

ANTIGENS, CD95; APOPTOSIS; BASE SEQUENCE; CARCINOMA, HEPATOCELLULAR; CASPASES; CELL LINE, TUMOR; DNA PRIMERS; DNA-BINDING PROTEINS; GENE SILENCING; HUMANS; IN SITU NICK-END LABELING; LIVER NEOPLASMS; MITOCHONDRIA, LIVER; TRANSCRIPTION FACTORS;

EID: 84880409646     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0068981     Document Type: Article

References (38)

1. Annick Buendia M, (2000) Genetics of hepatocellular carcinoma. Seminars in Cancer Biology 10: 185-200.
2. SunBH ZhaoXP, WangBJ YangDL, (2000) HaoLJ (2000) FADD and TRADD expression and apoptosis in primary human hepatocellular carcinoma. World Journal of Gastroenterology 6: 223-227.
3. Morrison DJ, Pendergrast PS, Stavropoulos P, Colmenares SU, Kobayashi R, (1999) FBI-1, a factor that binds to the HIV-1 inducer of short transcripts(IST), is a POZ domain protein. Nucleic Acids Res 27: 1251-1262.
4. Lee DK, (2002) POZ Domain Transcription Factor, FBI-1, Represses Transcription of ADH5/FDH by Interacting with the Zinc Finger and Interfering with DNA Binding Activity of Sp1. Journal of Biological Chemistry 277: 26761-26768.
5. Lin C-C, Zhou J-P, Liu Y-P, Liu J-J, Yang X-N, et al. (2012) The Silencing of Pokemon Attenuates the Proliferation of Hepatocellular Carcinoma Cells In Vitro and In Vivo by Inhibiting the PI3K/Akt Pathway. PLoS ONE 7: e51916.
6. Maeda T, (2005) The Transcription Factor Pokemon: A New Key Player in Cancer Pathogenesis. Cancer Research 65: 8575-8578.
7. Jeon BN, Yoo JY, Choi WI, Lee CE, Yoon HG, et al. (2008) Proto-oncogene FBI-1 (Pokemon/ZBTB7A) Represses Transcription of the Tumor Suppressor Rb Gene via Binding Competition with Sp1 and Recruitment of Co-repressors. Journal of Biological Chemistry 283: 33199-33210.
8. Choi WI, Jeon BN, Yun CO, Kim PH, Kim SE, et al. (2009) Proto-oncogene FBI-1 Represses Transcription of p21CIP1 by Inhibition of Transcription Activation by p53 and Sp1. Journal of Biological Chemistry 284: 12633-12644.
9. Lee DK, (2005) FBI-1 Enhances Transcription of the Nuclear Factor-κB (NF-κB)-responsive E-selectin Gene by Nuclear Localization of the p65 Subunit of NF-κB. Journal of Biological Chemistry 280: 27783-27791.
10. Fesik SW, (2005) Promoting apoptosis as a strategy for cancer drug discovery. Nature Reviews Cancer 5: 876-885.
11. Asnacios A, Fartoux L, Romano O, Tesmoingt C, Louafi S S, et al. (2008) Gemcitabine plus oxaliplatin (GEMOX) combined with cetuximab in patients with progressive advanced stage hepatocellular carcinoma. Cancer 112: 2733-2739.
12. Lim S-C, Choi JE, Kang HS, Si H (2009) Ursodeoxycholic acid switches oxaliplatin-induced necrosis to apoptosis by inhibiting reactive oxygen species production and activating p53-caspase 8 pathway in HepG2 hepatocellular carcinoma. International Journal of Cancer: NA-NA.
13. Nakamura M, Nagano H, Sakon M, Yamamoto T, Ota H, et al. (2007) Role of the Fas/FasL pathway in combination therapy with interferon-α and fluorouracil against hepatocellular carcinoma in vitro. Journal of Hepatology 46: 77-88.
14. Yin H, Xie F, Zhang J, Yang Y, Deng B, et al. (2011) Combination of interferon-α and 5-fluorouracil induces apoptosis through mitochondrial pathway in hepatocellular carcinoma in vitro. Cancer Letters 306: 34-42.
15. Kelley S, (2004) Targeting death receptors in cancer with Apo2L/TRAIL. Current Opinion in Pharmacology 4: 333-339.
16. MiyagishiM TairaK, (2002) U6 promoter-driven siRNAs with four uridine 3′ overhangs efficiently suppress targeted gene expression in mammalian cells. Nature biotechnology 19: 497-500.
17. Guleng B, (2005) Blockade of the Stromal Cell-Derived Factor-1/CXCR4 Axis Attenuates In vivo Tumor Growth by Inhibiting Angiogenesis in a Vascular Endothelial Growth Factor-Independent Manner. Cancer Research 65: 5864-5871.
18. Maeda T, Hobbs RM, Merghoub T, Guernah I, Zelent A, et al. (2005) Role of the proto-oncogene Pokemon in cellular transformation and ARF repression. Nature 433: 278-285.
19. Lee DK, Kang JE, Park HJ, Kim MH, Yim TH, et al. (2005) FBI-1 enhances transcription of the nuclear factor-kappaB (NF-kappaB)-responsive E-selectin gene by nuclear localization of the p65 subunit of NF-kappaB. J Biol Chem 280: 27783-27791.
20. Laudes M, Christodoulides C, Sewter C, Rochford JJ, Considine RV, et al. (2004) Role of the POZ zinc finger transcription factor FBI-1 in human and murine adipogenesis. J Biol Chem 279: 11711-11718.
21. Davies JM, Hawe N, Kabarowski J, Huang QH, Zhu J, et al. (1999) Novel BTB/POZ domain zinc-finger protein, LRF, is a potential target of the LAZ-3/BCL-6 oncogene. Oncogene 18: 365-375.
22. Aggarwal A, Hunter WJ, 3rd, Aggarwal H, Silva ED, Davey MS, et al (2010) Expression of leukemia/lymphoma-related factor (LRF/POKEMON) in human breast carcinoma and other cancers. Exp Mol Pathol 89: 140-148.
23. Ioana Berindan-Neagoe CBea (2013) 5-Fluorouracil Potentiates the Anti-Cancer Effect of Oxaliplatin on Colo320 Colorectal Adenocarcinoma Cells. J Gastrointestin Liver Dis 22 37-43.
24. Vogelstein B, Lane D, Levine AJ, (2000) Surfing the p53 network. Nature 408: 307-310.
25. Avery-Kiejda KA, Bowden NA, Croft AJ, Scurr LL, Kairupan CF, et al. (2011) P53 in human melanoma fails to regulate target genes associated with apoptosis and the cell cycle and may contribute to proliferation. BMC Cancer 11: 203.
26. Maetens M, Doumont G, Clercq SD, Francoz S, Froment P, et al. (2007) Distinct roles of Mdm2 and Mdm4 in red cell production. Blood 109: 2630-2633.
27. Cory S, Adams JM, (2002) The Bcl2 family: regulators of the cellular life-or-death switch. Nat Rev Cancer 2: 647-656.
28. Reed JC, (1997) Bcl-2 family proteins: regulators of apoptosis and chemoresistance in hematologic malignancies. Semin Hematol 34: 9-19.
29. Green DR, (2005) Apoptotic pathways: ten minutes to dead. Cell 121: 671-674.
30. Scovassi AI, Poirier GG, (1999) Poly(ADP-ribosylation) and apoptosis. Mol Cell Biochem 199: 125-137.
31. Kroemer G, Galluzzi L, Brenner C, (2007) Mitochondrial membrane permeabilization in cell death. Physiol Rev 87: 99-163.
32. Xiao CX, Yang XN, Huang QW, Zhang YQ, Lin BY, et al. (2012) ECHS1 acts as a novel HBsAg-binding protein enhancing apoptosis through the mitochondrial pathway in HepG2 cells. Cancer Lett.
33. Lee SH, Shin MS, Lee HS, Bae JH, Lee HK, et al. (2001) Expression of Fas and Fas-related molecules in human hepatocellular carcinoma. Hum Pathol 32: 250-256.
34. Abd El-Ghany RM, Sharaf NM, Kassem LA, Mahran LG, Heikal OA, (2009) Thymoquinone triggers anti-apoptotic signaling targeting death ligand and apoptotic regulators in a model of hepatic ischemia reperfusion injury. Drug Discov Ther 3: 296-306.
35. Okamoto K, Kobayashi T, Kobata T, Hasunuma T, Kato T, et al. (2000) Fas-associated death domain protein is a Fas-mediated apoptosis modulator in synoviocytes. Rheumatology (Oxford) 39: 471-480.
36. Lin S, Liu X, Yin R, Kong D, Qu Y, et al. (2009) Inhibitory effects of short hairpin RNA against caspase-8 on apoptosis of murine hepatoma Hepa1-6 cells. Biosci Trends 3: 53-57.
37. Fulda S, (2009) Caspase-8 in cancer biology and therapy. Cancer Lett 281: 128-133.
38. Qi F, Li A, Inagaki Y, Xu H, Wang D, et al. (2012) Induction of apoptosis by cinobufacini preparation through mitochondria- and Fas-mediated caspase-dependent pathways in human hepatocellular carcinoma cells. Food Chem Toxicol 50: 295-302.